retatrutide update october 2025 27, 2025: U.K. regulators bust illicit site making unlicensed and tirzepatide pens – Partnership for Safe Medicines Retatrutide Phase 3: TRIUMPH Program

Meanwhile, a post-hoc analysis of the STEP 1 and STEP 4 trials showed that semaglutide 2.4 mg was associated with an approximately 60% reduction of the 10-years risk of T2D according to the Cardiometabolic Disease Staging (CMDS) calculator, regardless of patients baseline glycemic status 74

Incremental digital improvements will fade into the background as AI advances steal the spotlight A few years ago, you couldnt talk to anyone in the clinical trials space without hearing about the belle of the ball: decentralised trials

(Lees papers were not randomized and did not use control groups

Sweating typically subsides once your body acclimates